Pupil response to negative facial expressions predicts risk for depression relapse

Pupil dilation in reaction to negative emotional faces predicts risk for depression relapse, according to new research from Binghamton University, State University of New York. Researchers at Binghamton University, led by PhD student Anastacia Kudinova, aimed to examine whether physiological reactivity to emotional stimuli, assessed via pupil dilation, served as a biological marker of riskContinue reading “Pupil response to negative facial expressions predicts risk for depression relapse”

Mechanism of Rapid Antidepressant Effect of Alcohol Elucidated

by Tori Rodriguez, MA, LPC Individuals with major depressive disorder (MDD) have double the risk of alcohol use disorders (AUDs) and vice versa, and it has previously been proposed that some people with MDD may use alcohol to self-medicate. Though alcohol can become depressant if used chronically, alcohol initially has an antidepressant effect, though theContinue reading “Mechanism of Rapid Antidepressant Effect of Alcohol Elucidated”

New study shows that brief hyperthermia treats depression

Whole-body hyperthermia is a promising antidepressant modality that works quickly and offers prolonged benefit, according to a study recently published in the online JAMA Psychiatry. Researchers came to that conclusion after conducting a double-blind study that randomized 30 adults with major depressive disorder to either a single session of active whole-body hyperthermia or a shamContinue reading “New study shows that brief hyperthermia treats depression”

New drug for postpartum depression succeeds in mid-stage study

By Natalie Grover Sage Therapeutics Inc said its drug alleviated symptoms of severe postpartum depression, meeting the main goal of a small mid-stage study and sending the company’s shares soaring. About one in seven women experience postpartum depression that eventually interferes with her ability to take care of the baby and handle daily tasks, accordingContinue reading “New drug for postpartum depression succeeds in mid-stage study”

Virtual Reality Therapy Shows Promise Against Depression

An immersive virtual reality therapy could help people with depression to be less critical and more compassionate towards themselves, reducing depressive symptoms, finds a new study from UCL (University College London) and ICREA-University of Barcelona. The therapy, previously tested by healthy volunteers, was used by 15 depression patients aged 23-61. Nine reported reduced depressive symptomsContinue reading “Virtual Reality Therapy Shows Promise Against Depression”

Risk of suicide increases 3X after a concussion

New research published in the Canadian Medical Association Journal shows that even mild concussions sustained in ordinary community settings might be more detrimental than anyone anticipated; the long-term risk of suicide increases threefold in adults if they have experienced even one concussion. That risk increases by a third if the concussion is sustained on aContinue reading “Risk of suicide increases 3X after a concussion”

The Power of Music in Alleviating Dementia Symptoms

by Tori Rodriguez, MA, LPC As the search continues for effective drug treatments for dementia, patients and caregivers may find some measure of relief from a common, non-pharmaceutical source. Researchers have found that music-related memory appears to be exempt from the extent of memory impairment generally associated with dementia, and several studies report promising resultsContinue reading “The Power of Music in Alleviating Dementia Symptoms”

New study identifies potential new class of more rapidly acting antidepressant medications

A new study by researchers at University of Maryland School of Medicine has identified promising compounds that could successfully treat depression in less than 24 hours while minimizing side effects. Although they have not yet been tested in people, the compounds could offer significant advantages over current antidepressant medications. The research, led by Scott Thompson,Continue reading “New study identifies potential new class of more rapidly acting antidepressant medications”

Antidepressant Clinical Trials Exclude about 80% of People with Depression

A provocative new study suggests that more than 80 percent of people with depression in the general population aren’t eligible for clinical trials of antidepressant drugs. Researchers comment that at least five patients would need to be screened to enroll just one patient meeting the typical inclusion and exclusion criteria for antidepressant registration trials (ARTs).Continue reading “Antidepressant Clinical Trials Exclude about 80% of People with Depression”

Meet the Man Trying to Use Ayahuasca to Treat PTSD

Deep in the Amazon rainforest, a group of veterans chokes down a gritty, gut-wrenching shot of liquid absolution. They try to drink away their severe mental disturbances, but not the way you drink away your ex-girlfriend with a bottle of whiskey. They’re looking for a cure. Their leader: 27-year-old retired infantryman Ryan LeCompte. Their goal:Continue reading “Meet the Man Trying to Use Ayahuasca to Treat PTSD”